Versant Capital strategically boosts Dimensional ETFs, trims major holdings in Q2 13F

AVEM is a relatively concentrated position for Versant, accounting for 3.2% of its holdings and ranking as its 5th largest position after Versant trimmed to 371,481 shares, valued at about $35.84 million at the end of the period.
Dimensional Emerging Markets Value ETF (DFEV) saw a sizable increase, with Versant holding 138,902 shares after adding 60,401 during the quarter, a 76.9% rise and valued at roughly $5.93 million.
Dimensional U.S. Core Equity 2 ETF (DFAC) rose to 954,017 shares, up 32,564 in the quarter; the position represents 3.8% of Versant’s holdings and is its 4th largest, with a value around $42.32 million.
Versant trimmed JPMorgan Chase & Co. (JPM) by 12.6% to 10,685 shares, reducing value to about $3.50 million, reflecting continued selective disposition in large-cap financials.
Dimensional US Vector Equity ETF (DXUV) position surged to 170,886 shares, up 129,742 shares (315.3%), making it roughly 1.0% of Versant’s portfolio and about 2.59% of the ETF itself, valued at around $11.36 million and ranking as the 16th largest holding.
Versant Capital Management Inc made sweeping changes to its ETF portfolio in the second quarter, with its 13F filing revealing both big trims and dramatic additions across several funds. The most striking move was a 315.3% surge in its Dimensional US Vector Equity ETF (DXUV) position, which jumped by 129,742 shares to reach 170,886 shares, valued at about $11.36 million, according to Watchlist News.
At the same time, Versant pulled back on some existing stakes. It cut its JPMorgan Chase & Co. (JPM) holding by 12.6% to 10,685 shares, worth roughly $3.50 million. The flurry of moves points to a firm leaning heavily into Dimensional and Avantis fund strategies while trimming select large-cap stock exposure.
The DXUV position was the quarter's biggest percentage gainer for Versant. The firm added 129,742 shares, a 315.3% increase. That move made DXUV its 16th largest holding and pushed Versant's ownership to about 2.59% of the entire ETF, per Watchlist News.
Versant also sharply expanded its bet on emerging markets value. Its Dimensional Emerging Markets Value ETF (DFEV) stake grew 76.9% after the firm added 60,401 shares. The position now stands at 138,902 shares, valued at roughly $5.93 million, according to Ticker Report.
Versant's position in Dimensional U.S. Core Equity 2 ETF (DFAC) climbed 3.5% during the quarter. The firm added 32,564 shares, bringing its total to 954,017 shares. That makes DFAC its 4th largest holding, representing 3.8% of its total portfolio.
The position is valued at around $42.32 million. The steady build in DFAC shows Versant's continued confidence in broad U.S. equity exposure through factor-based funds, which target specific traits like value and profitability rather than simply tracking a plain index.
Not all moves were additions. Versant cut its Avantis Emerging Markets Equity ETF (AVEM) stake by 2.5%, reducing it to 371,481 shares worth about $35.84 million. Despite the trim, AVEM remains the firm's 5th largest holding at 3.2% of total assets, per Watchlist News.
Versant also reduced its JPMorgan Chase stake by 12.6%, leaving just 10,685 shares valued at $3.50 million. The JPM cut reflects a broader pattern of trimming individual large-cap stocks while growing exposure to diversified factor-based ETFs.
Beyond its headline moves, Versant also bought 194,964 shares of Dimensional Emerging Markets Core Equity 2 ETF (DFEM), making it the firm's 9th largest holding at 501,593 total shares, according to Ticker Report.
The firm also boosted its Dimensional International Vector Equity ETF (DXIV) position by 124.7%, pushing that stake to a value of $7.71 million, per Ticker Report. Taken together, these moves show Versant building a globally diversified, factor-driven ETF portfolio while selectively reducing single-stock risk.
Publishers
22
Articles
6
Reach
28